Market Overview

Kindred Biosciences (NASDAQ: KIN)

9.66 -0.43 (-4.26%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/16/19B. RileyDowngradesNeutral8.5
6/11/19BarclaysInitiates Coverage OnOverweight13.0
5/23/19Stifel NicolausInitiates Coverage OnBuy14.0
10/31/18Cantor FitzgeraldMaintainsOverweight25.0
8/07/18B. Riley FBRMaintainsBuy16.0
8/07/18Ladenburg ThalmannDowngradesNeutral
7/24/18Cantor FitzgeraldInitiates Coverage OnOverweight20.0
7/23/18Lake StreetInitiates Coverage OnBuy30.0
11/17/17H.C. WainwrightInitiates Coverage OnBuy9.5
6/16/17Aegis CapitalInitiates Coverage OnBuy10.5

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter